Clinical Trial Update: Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating RLX030 for safety and efficacy in pregnant women with pre-eclampsia was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pre-eclampsia

Drugs mentioned

• RLX030

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Pre-eclampsia | Phase 2 | Status: TERMINATED | Results posted: 2015-11-05